Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives. DONALD G. McNEIL Jr. https://nyti.ms/2VRY6qm http://bit.ly/2WxOspX The New York Times Health Acquired Immune Deficiency Syndrome, Truvada (Drug), State of the Union Message (US), Drugs (Pharmaceuticals) May 9, 2019 at 12:00AM